Debiopharm – a Swiss pharma company that has licensed-in one of PSIs developments -a compound with high potential for cancer diagnosis & therapy has been nominated for the “2019/2020 Swiss Biotech Sucess Stories Awards”
We will keep our fingers crossed for Debiopharm a Swiss-based company that constantly furthers and supports Swiss research, Swiss IP and Swiss jobs…
Bertrand Ducrey, CEO (left) and Fabien Sebille, Director Business Development & Commercial Insights (right)